Global Pneumococcal Vaccines Market Booms Amid Rising Demand for Adult Immunization and Pneumonia Prevention 2025 | Top Key Players - Pfizer Inc., Merck & Co., Inc., SINOVAC.

The Global Pneumococcal Vaccines Market reached US$ 7.96 billion in 2023 and is expected to reach US$ 11.9 billion by 2031 growing with a CAGR of 5.2% during the forecast period 2024-2031.

The latest Pneumococcal Vaccines market research report from DataM Intelligence delivers a comprehensive analysis of the global Pneumococcal Vaccines Market landscape, highlighting emerging trends, market size, competitive dynamics, and key growth drivers. This high-impact report offers strategic insights for investors, marketers, and decision-makers looking to capitalize on current and future market opportunities.

Download exclusive insights with our detailed sample report (Corporate Email ID to get priority access) @ https://datamintelligence.com/download-sample/pneumococcal-vaccines-market?sz

The Pneumococcal Vaccines Market refers to the global industry involved in the research, production, distribution, and sale of vaccines that protect against Streptococcus pneumoniae infections. These vaccines help prevent illnesses such as pneumonia, meningitis, and sepsis. The market includes various vaccine types, including conjugate and polysaccharide vaccines, targeting different age groups and high-risk populations across developed and developing regions.

Market Segments

By Type: Pneumococcal Conjugate Vaccine (PCV), Pneumococcal Polysaccharide Vaccine (PPV), Next Generation Pneumococcal Vaccines.

By Route of Administration: Intramuscular, Subcutaneous.

By Patient Type: Infants (< 1 Year), Children (1-12 Years), Adolescence (13-19 Years), Adults (20-60 Years), Geriatrics (Above 60 Years).

The Pneumococcal Vaccines industry is undergoing swift expansion, fueled by breakthroughs in medical technology, growing demand for cutting-edge therapies, and an increasing emphasis on patient-centric care. As the sector advances, in-depth market analysis is essential to track evolving trends, regulatory developments, and new opportunities.

Prominent players in the Pneumococcal Vaccines Market

The prominent players in Pneumococcal Vaccines market research report are: Pfizer Inc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Walvax Biotechnology Co., Ltd., SINOVAC, Beijing Minhai Biological Technology Co., Ltd., SK bioscience., Sanofi, Biological E Limited., CanSinoBIO, Panacea Biotec, GSK plc. and Inventprise among others.

These companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Industry Developments:

In June 2024, Merck received FDA approval for CAPVAXIVE, a 21-valent pneumococcal conjugate vaccine. Designed for adults, the vaccine helps prevent invasive pneumococcal disease (IPD) and pneumococcal pneumonia. CAPVAXIVE targets the Streptococcus pneumoniae serotypes most commonly linked to severe cases in individuals aged 50 and older, offering broader protection for a vulnerable population.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/pneumococcal-vaccines-market

Regions Covered:

The global Pneumococcal Vaccines Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

FAQs:

✒ What are the primary drivers fueling growth in the Pneumococcal Vaccines Market today?
✒ Which companies are currently leading innovation and market share in the Pneumococcal Vaccines Market?
✒ In what ways is the current regulatory environment influencing the Pneumococcal Vaccines Market's trajectory?
✒ Which geographic regions are forecasted to experience the strongest growth in the Pneumococcal Vaccines Market-and why?
✒ What are the key barriers or challenges that could limit the growth of the Pneumococcal Vaccines Market?

Buy Now & Unlock 360° Market Intelligence: https://datamintelligence.com/buy-now-page?report=pneumococcal-vaccines-market?sz

Purchase Your Subscription to Power Your Strategy with Precision: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.